ConductScience.org, home

Paper33716004

Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes.

Ciardullo S and 1 other. Metabolism, 2021. Cited by 92 papers, by iCite.

Cite this record

ConductScience Library. Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes. Papers, record 33716004. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33716004

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes.
PubMed
Journal
Metabolism
PubMed
Year
2021
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
92
iCite
Relative citation ratio, by iCite
6.3
iCite
Revised in PubMed
2021-10-05
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ciardullo SStefano
2Perseghin GGianluca

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetes Mellitus, Type 2Major topic
Hydroxymethylglutaryl-CoA Reductase InhibitorsMajor topic
Liver CirrhosisMajor topic
Aged
Cross-Sectional Studies
Disease Progression
Elasticity Imaging Techniques
Female
Humans
Italy
Liver
Male
Middle Aged
Non-alcoholic Fatty Liver Disease
Nutrition Surveys
Prevalence

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT05987748The Clock Thickens: Morning or Evening Training for the Treatment of NAFLD?Background

Source ClinicalTrials.gov

Download CSV of trials

Cited by72

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 92 citations.

PMIDTitleJournalYearIn PapersSource
42877484The association of cardiovascular disease (CVD) with progression of advanced fibrosis risk in patients with metabolic dysfunction-associated steatotic liver disease (MASLD).Livers2026https://conductscience.org/library/papers/42877484PubMed
42872191Metabolic dysfunction-associated steatotic liver disease assessment and management: Clinical practice guidance from the Canadian Association for the Study of the Liver.Can Liver J2026https://conductscience.org/library/papers/42872191PubMed
41970192Metabolic Dysfunction-associated Steatotic Liver Disease and Chronic Kidney Disease: From Epidemiology and Pathophysiology to Clinical Prediction and Treatment Options.J Clin Transl Hepatol2026https://conductscience.org/library/papers/41970192PubMed
41718130Efficacy and Safety of Statins in MASLD and Other Chronic Liver Diseases.Med Sci (Basel)2026https://conductscience.org/library/papers/41718130PubMed
41676424High-density lipoprotein cholesterol and nuclear factor I A in type 2 diabetes and mild cognitive impairment: biomarkers and mechanistic insights.Arch Med Sci2025https://conductscience.org/library/papers/41676424PubMed
41522334Transient Elastography and Fibroscan: Stethoscope of a Hepatologist in Today's World.Curr Hepatol Rep2025https://conductscience.org/library/papers/41522334PubMed
41455979The importance of sex dimorphism in liver metabolism and progressive liver diseases.Biol Sex Differ2025https://conductscience.org/library/papers/41455979PubMed
41356318Cardiovascular Health in the Shadow of Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease: An Emerging Paradigm.Rev Cardiovasc Med2025https://conductscience.org/library/papers/41356318PubMed
41324115Correlation of Lymphocyte-to-C-Reactive Protein Ratio With Erectile Dysfunction Risk in United States Adult Males during 2001-2004: A Cross-Sectional Analysis.Health Sci Rep2025https://conductscience.org/library/papers/41324115PubMed
41127403Knowledge, Attitudes, and Practices of Elderly Diabetic Patients and Their Families Regarding Comorbid Non-Alcoholic Fatty Liver Disease: A Structural Equation Modeling Analysis.Diabetes Metab Syndr Obes2025https://conductscience.org/library/papers/41127403PubMed
41113904Proteome Profiling Identifies CDH2 as a Potential Screening Marker for NAFLD and Liver Fibrosis in the Snoring Population.Nat Sci Sleep2025https://conductscience.org/library/papers/41113904PubMed
41026784Evaluating liver type fatty acid binding protein as a diagnostic and prognostic biomarker in metabolic dysfunction-associated steatotic liver disease in pediatric patients.PLoS One2025https://conductscience.org/library/papers/41026784PubMed
40937081Assessment of Metabolic Dysfunction-associated Steatotic Liver Disease and Liver Fibrosis: A Cross-sectional Study in Asymptomatic Individuals in Greater Vancouver.J Clin Transl Hepatol2025https://conductscience.org/library/papers/40937081PubMed
40630174The association of dietary nutrients consumption with hepatic steatosis and fibrosis from NHANES 2017-2020.Front Nutr2025https://conductscience.org/library/papers/40630174PubMed
40596311Utility of the serum alanine aminotransferase to high density lipoprotein cholesterol ratio in evaluating nonalcoholic fatty liver disease and liver fibrosis.Sci Rep2025https://conductscience.org/library/papers/40596311PubMed
40427477Protective Effects of Lotus Seedpod Extract on Hepatic Lipid and Glucose Metabolism via AMPK-Associated Mechanisms in a Mouse Model of Metabolic Syndrome and Oleic Acid-Induced HepG2 Cells.Antioxidants (Basel)2025https://conductscience.org/library/papers/40427477PubMed
40425766Nonlinear relationship between serum high sensitivity C reactive protein to high density lipoprotein cholesterol ratio with non-alcoholic fatty liver disease.Sci Rep2025https://conductscience.org/library/papers/40425766PubMed
40333820Relationship between the systemic immune-inflammatory index and overactive bladder risk: A cross-sectional assessment involving United States Adults.PLoS One2025https://conductscience.org/library/papers/40333820PubMed
40251275Mortality among individuals with chronic kidney disease based on the 2012 and 2021 KDIGO blood pressure targets.Sci Rep2025https://conductscience.org/library/papers/40251275PubMed
40226389Factors Associated With Advanced Liver Fibrosis in a Population With Type 2 Diabetes: A Multicentric Study in Mexico City.J Clin Exp Hepatol2025https://conductscience.org/library/papers/40226389PubMed

See all 72 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33716004

GET https://conductscience.org/api/papers/v1/33716004/cited_by?page=2